Seborrheic Dermatitis
📧 Sign up to get email alerts when something new happens for Seborrheic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Safety and Efficacy Study in Subjects With Seborrheic Dermatitis [Phase 2]
Phase 2 safety and efficacy study in seborrheic dermatitis has completed.
-
FDA label_change · 2012-09-07FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories, L.P. The approval updates the product…
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis [Phase 4]
Phase 4 clinical trial assessing proactive tacrolimus ointment for adult facial seborrheic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis [NA]
Open-label clinical trial evaluating the HairMax LaserComb device for treating seborrheic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% [Phase 4]
This Phase 4 trial update reports the long-term safety results of Extina (ketoconazole) 2% foam for seborrheic dermatitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea [Phase 4]
A Phase 4 clinical trial update assesses the efficacy and safety of low-dose oral isotretinoin for seborrhea and seborrheic dermatitis, incl…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage [Phase 2]
Phase 2 clinical trial update evaluating Topically Dissolved Oxygen (TDO) to reduce signs of photodamage. The study includes rosacea, acne v…
-
FDA approval · 2010-09-17FDA Approved: NIZORAL — Supplemental Application (Kramer Laboratories)
FDA approved a supplemental application for NIZORAL (ketoconazole) from Kramer Laboratories, resulting in labeling updates for the product.
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp [Phase 3]
Phase 3 trial update indicates completion of the K301 study for seborrheic dermatitis of the scalp.
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face
A clinical trial update evaluating the effectiveness of a product containing topical hydrocortisone for facial seborrheic dermatitis.
-
CLINICAL_TRIALS trial_result · 2009-11-11Clinical Trial Update: Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis [Phase 3]
Phase 3 trial comparing prednisolone acetate 0.5% cream with betamethasone valerate 0.1% cream to assess efficacy and tolerability in cortic…
-
FDA approval · 2009-03-18FDA Approved: KETOCONAZOLE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approved a supplemental ANDA for Ketoconazole, a generic antifungal product from E. Fougera & Co. (division of Fougera Pharmaceuticals).
-
CLINICAL_TRIALS trial_result · 2008-10-07Clinical Trial Update: Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients [Phase 1]
Phase 1 trial investigating botulinum toxin for seborrheic dermatitis in Parkinsonian patients; current status is unknown.
-
FDA approval · 2008-09-23FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original ANDA for topical betamethasone dipropionate, a generic corticosteroid, for inflammatory skin conditions…
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis [Phase 3]
A Phase 3 trial evaluating ASF1057 for seborrheic dermatitis has completed, assessing efficacy and safety.
-
FDA label_change · 2007-12-12FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) submitted by Royal Pharmaceuticals, typically resulting in updat…
-
FDA approval · 2006-08-14FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)
FDA approves a supplemental application for clobetasol propionate from E. Fougera & Co. (division of Fougera Pharmaceuticals Inc.), under th…